BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22445557)

  • 1. Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.
    Dijkstra MG; Heideman DA; van Kemenade FJ; Hogewoning KJ; Hesselink AT; Verkuijten MC; van Baal WM; Boer GM; Snijders PJ; Meijer CJ
    J Clin Virol; 2012 Jun; 54(2):147-51. PubMed ID: 22445557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
    BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
    Gök M; van Kemenade FJ; Heideman DA; Berkhof J; Rozendaal L; Spruyt JW; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
    Int J Cancer; 2012 Mar; 130(5):1128-35. PubMed ID: 21484793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
    Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
    J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women.
    van Baars R; Bosgraaf RP; ter Harmsel BW; Melchers WJ; Quint WG; Bekkers RL
    J Clin Microbiol; 2012 Dec; 50(12):3937-43. PubMed ID: 23015677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
    Rohner E; McGuire FH; Liu Y; Li Q; Miele K; Desai SA; Schmitt JW; Knittel A; Nelson JAE; Edelman C; Sivaraman V; Baker A; Romocki LS; Rahangdale L; Smith JS
    J Womens Health (Larchmt); 2020 Jul; 29(7):971-979. PubMed ID: 32212991
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush.
    Brink AA; Meijer CJ; Wiegerinck MA; Nieboer TE; Kruitwagen RF; van Kemenade F; Fransen Daalmeijer N; Hesselink AT; Berkhof J; Snijders PJ
    J Clin Microbiol; 2006 Jul; 44(7):2518-23. PubMed ID: 16825374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
    Tranberg M; Jensen JS; Bech BH; Andersen B
    BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
    Hesselink AT; Heideman DA; Berkhof J; Topal F; Pol RP; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2010 Mar; 48(3):797-801. PubMed ID: 20042622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.
    Rohner E; Rahangdale L; Sanusi B; Knittel AK; Vaughan L; Chesko K; Faherty B; Tulenko SE; Schmitt JW; Romocki LS; Sivaraman V; Nelson JAE; Smith JS
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia.
    Berggrund M; Gustavsson I; Aarnio R; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
    Virol J; 2019 Nov; 16(1):146. PubMed ID: 31771594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+: A randomized study.
    Aarnio R; Isacson I; Sanner K; Gustavsson I; Gyllensten U; Olovsson M
    Int J Cancer; 2021 Jun; 148(12):3051-3059. PubMed ID: 33497465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
    Leinonen MK; Schee K; Jonassen CM; Lie AK; Nystrand CF; Rangberg A; Furre IE; Johansson MJ; Tropé A; Sjøborg KD; Castle PE; Nygård M
    J Clin Virol; 2018; 99-100():22-30. PubMed ID: 29289814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
    Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
    Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
    J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.